MedTrace Logo

Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes

NCT04113694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2021-10-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to collect confirmatory clinical data to support 6 or 7 days wear of EWIS (Extended Wear Infusion Set).

Conditions

Interventions

DEVICE

Extended Infusion Set

Each subject is asked to wear each Extended Wear Infusion Set for at least 174 hours.

Sponsors & Collaborators

  • Medtronic Diabetes

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2020-11-05
Completion
2020-11-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04113694 on ClinicalTrials.gov